Eli***rse

Director, Business Development

Education

The Wharton School

The Wharton School (2018 - 2020)

  • Degree: Master of Business Administration - MBA
  • Field of Study: Healthcare Management
  • Description: Director’s List Fellowship recipient Kaiser Family Foundation Prize recipient Kinney Scholarship recipient Kaiser Fellowship recipient

Dartmouth College (2011 - 2015)

  • Degree: Bachelor of Arts (B.A.)
  • Field of Study: Biology (Molecular Genetics), Psychology
  • Description: James O. Freedman Presidential Scholar Cum Laude Honors in Biology Thomas B. Roos Memorial Fund Fellowship

Winston Churchill High School (2007 - 2011)

  • Degree: Unknown Degree
  • Field of Study: Unknown Field
  • Description:

Skills:

Interpersonal Communication, Due Diligence, Strategic Consulting, Oncology

Work Experience:

Director, Business Development at Olema Oncology

  • Location: Cambridge, Massachusetts, United States
  • Duration: 2023-10 to Present
  • Description:

Associate Director, Business Development at Alnylam Pharmaceuticals

  • Location: Cambridge, Massachusetts, United States
  • Duration: 2022-07 to 2023-10
  • Description:

Senior Manager, Business Development at Alnylam Pharmaceuticals

  • Location: Cambridge, Massachusetts, United States
  • Duration: 2020-08 to 2022-06
  • Description: - Lead/Support BD deals through all stages of the deal process from search and evaluation through agreement negotiation for all types of transactions (In and out licensing, collaboration agreements, evaluation agreements, MTAs, etc.) with a focus on transaction execution - Responsible for diligencing and prioritizing deals in close collaboration with R&D and commercial, as well as deal valuations and comps analysis

Business Development and Corporate Development Intern at Pyxis Oncology

  • Location: Cambridge, Massachusetts, United States
  • Duration: 2020-06 to 2020-08
  • Description: - Support licensing and partnering BD deals including leading cross-functional due diligence, building business cases for deals, developing deal financial models, and incorporating business issues into term sheets - Prepared BOD and Series B pitch materials

Business Leadership Development Intern at Regeneron Pharmaceuticals, Inc.

  • Location: Tarrytown, New York
  • Duration: 2019-06 to 2019-08
  • Description: MBA Summer Associate, Oncology New Products
AI Resume Analysis

Candidate Intelligence Report

AI-powered analysis from the perspective of a US hiring director — evaluating career continuity, growth trajectory, and role fit.

Career Continuity & Risk Assessment

Employment GapLow

No material employment gap; the brief 2019–2020 transition is explained by MBA-related internships and program timing, followed by continuous BD-focused roles in oncology.

Industry ConsistencyLow

Career is concentrated in oncology BD across multiple biotech companies, showing strong industry alignment and domain expertise with increasing deal-execution responsibilities.

Tenure StabilityLow

Progression from Senior Manager to Associate Director to Director within a clear succession path at compatible firms demonstrates stability and growth, including a multi-year tenure at Alnylam before moving to Olema.

Education-Career MatchLow

Wharton education aligns well with advanced BD leadership in biopharma, complemented by hands-on deal origination, diligence, and financial modeling experience.

Career Growth Curve

Business Leadership Development Intern Entry
Regeneron Pharmaceuticals, Inc.
2019-06 to 2019-08
Business Development and Corporate Development Intern Entry
Pyxis Oncology
2020-06 to 2020-08
Senior Manager, Business Development ↑ Promoted
Alnylam Pharmaceuticals
2020-08 to 2022-06
Associate Director, Business Development ↑ Promoted
Alnylam Pharmaceuticals
2022-07 to 2023-10
Director, Business Development ↑ Promoted
Olema Oncology
2023-10 to Present
Assessment: Elizabeth Morse presents a consistent upward trajectory within oncology BD, with progressive responsibilities in deal sourcing, diligence, valuation, and cross-functional leadership. With an MBA from Wharton and a solid track record at Alnylam and Olema, she is well-positioned for senior leadership (VP/Head of BD) in oncology-focused biopharma or biotech.

Best-Fit Roles (Top 5)

1

Vice President, Business Development – Oncology96% fit

Direct progression from Director in oncology BD, plus MBA credentials and proven record of end-to-end deal leadership across licensing, partnerships, and collaborations; ready to lead a BD function and strategy at scale.

2

Head of Business Development – Oncology92% fit

Strategic leadership across pipeline prioritization, cross-functional alignment, and negotiations; strong track record in deal execution makes she a strong candidate to own the BD strategy for a growth-stage or mid-cap biotech.

3

Senior Director, Corporate Development – Oncology89% fit

Advanced BD leadership with experience managing complex transactions and valuations; suitable for larger teams and broader portfolio oversight in a larger organization.

4

Director, Strategic Partnerships – Biotech/Pharma82% fit

Strong alignment with alliance management and cross-functional deal execution; good fit for organizations seeking to optimize external collaborations and co-development deals.

5

Director, Licensing & Partnerships – Oncology78% fit

Specialized licensing/partnerships focus aligns with prior BD experience; suitable for roles emphasizing licensing strategy and deal structuring within oncology.

Experience AI Recruiter

$0 to start. Don't let your competitors get the AI advantage first.

Join over 10,000 companies using AI-driven recruitment solutions to automate your hiring process and save 80% in time costs.

33% off, only 48 hours left!
Try AI Free

24/7 automated operation

AI-powered candidate screening

Recruitment without geographical or time zone limitations

Personalized intelligent communication

Automated assessment of candidate engagement

Intelligently mimics and replicates your recruitment style

4-month money-back guarantee

Ensures LinkedIn account security